Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of <i>Clostridioides difficile</i> Infection
Fidaxomicin, a macrocyclic antibiotic, selectively kills <i>Clostridioides difficile</i> and reduces <i>C. difficile</i> infection (CDI) recurrence compared with vancomycin, but some studies and guidelines report fidaxomicin as being less cost-effective. The aim of this study...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Llibre |
| Publicat: |
MDPI AG,
2023-01-01T00:00:00Z.
|
| Matèries: | |
| Accés en línia: | Connect to this object online. |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Còpia 1 | Disponible |